Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 467

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 467
---
 and individuals affiliated with 65 E Cedar, Suite 2, Zionsville, IN 46077.                                                                                                           |

| (4) | Based solely on a Schedule 13D filed with the SEC on September 3, 2024, the beneficial ownership shown                                                                                                                                             
 above consists of (i) 1,736,015 shares that are held by EcoR1 Capital Fund Qualified, L.P. (“Qualified Fund”) and (ii) 109,238 shares that are held by EcoR1 Capital, LLC (“EcoR1”). EcoR1 is the general partner of Qualified Fund.               
 Oleg Nodelman is the control person of EcoR1 and may be deemed to share dispositive voting power over the shares held by the Qualified Fund. Mr. Nodelman and EcoR1 both disclaim beneficial ownership of all shares except to the extent of their 
 pecuniary interest. The address for EcoR1 Capital LLC, the EcoR1 Capital Funds and Oleg Nodelman is 357 Tehama Street #3, San Francisco, CA.                                                                                                       |

| (5) | Consists of (i) 22,869 shares of common stock held directly by Mr. Lennon; (ii) 226,601 shares issuable                                                                            
 upon the exercise of options within 60 days of December 31, 2024; and (iii) 16,250 shares issuable upon the vesting of restricted stock units within 60 days of December 31, 2024. |

| (6) | Consists of (i) 7,822 shares of common stock held directly by Mr. Giacobello; (ii) 443,345 shares issuable                                                                        
 upon the exercise of options within 60 days of December 31, 2024; and (iii) 6,750 shares issuable upon the vesting of restricted stock units within 60 days of December 31, 2024. |

| (7) | Consists of (i) 192,996 shares of common stock issuable upon the exercise of options within 60 days of                            
 December 31, 2024 and (ii); 5,000 shares issuable upon the vesting of restricted stock units within 60 days of December 31, 2024. |

| (8) | Consists of (i) 1,171,543 shares of common stock held indirectly by the Anishka Family Trust, (ii) 639